Background Multiple treatments are effective for major depressive disorder (MDD), but the outcomes of each treatment vary broadly among individuals. Accurate prediction of outcomes is needed to help select a treatment that is likely to work for a given person. We aim to examine the performance of machine learning methods in delivering replicable predictions of treatment outcomes. Methods Of 7732 non-duplicate records identified through literature search, we retained 59 eligible reports and extracted data on sample, treatment, predictors, machine learning method, and treatment outcome prediction. A minimum sample size of 100 and an adequate validation method were used to identify adequate-quality studies. The effects of study features on prediction accuracy were tested with mixed-effects models. Fifty-four of the studies provided accuracy estimates or other estimates that allowed calculation of balanced accuracy of predicting outcomes of treatment. Results Eight adequate-quality studies reported a mean accuracy of 0.63 [95% confidence interval (CI) 0.56–0.71], which was significantly lower than a mean accuracy of 0.75 (95% CI 0.72–0.78) in the other 46 studies. Among the adequate-quality studies, accuracies were higher when predicting treatment resistance (0.69) and lower when predicting remission (0.60) or response (0.56). The choice of machine learning method, feature selection, and the ratio of features to individuals were not associated with reported accuracy. Conclusions The negative relationship between study quality and prediction accuracy, combined with a lack of independent replication, invites caution when evaluating the potential of machine learning applications for personalizing the treatment of depression.

In this article, we consider the discretized classical Susceptible-Infected-Recovered (SIR) forced epidemic model to investigate the consequences of the introduction of different transmission rates and the effect of a constant vaccination strategy, providing new numerical and topological insights into the complex dynamics of recurrent diseases. Starting with a constant contact (or transmission) rate, the computation of the spectrum of Lyapunov exponents allows us to identify different chaotic regimes. Studying the evolution of the dynamical variables, a family of unimodal-type iterated maps with a striking biological meaning is detected among those dynamical regimes of the densities of the susceptibles. Using the theory of symbolic dynamics, these iterated maps are characterized based on the computation of an important numerical invariant, the topological entropy. The introduction of a degree (or amplitude) of seasonality, ε, is responsible for inducing complexity into the population dynamics. The resulting dynamical behaviors are studied using some of the previous tools for particular values of the strength of the seasonality forcing, ε. Finally, we carry out a study of the discrete SIR epidemic model under a planned constant vaccination strategy. We examine what effect this vaccination regime will have on the periodic and chaotic dynamics originated by seasonally forced epidemics.

No abstract

Major depressive disorder, referred to as depression, is a leading cause of disability, absence from work, and premature death. Automatic assessment of depression from speech is a critical step towards improving diagnosis and treatment of depression. Previous works on depression assessment from speech considered various acoustic features extracted from speech to estimate depression severity. But performance of these approaches is not at clinical standards, and thus requires further improvement. In this work, we examine two novel approaches for improving depression severity estimation from short audio recordings of speech. Specifically, in audio recordings of a narrative by individuals diagnosed with major depressive disorder, we analyze spectral-based and excitation source-based features extracted from speech, and significance of sentiment and emotion classification in estimation of depression severity. Initial results indicate synchrony between depression scores and the sentiment and emotion labels. We propose the use of sentiment and emotion based embeddings obtained using machine learning techniques in estimation of depression severity. We also propose use of multi-task training to better estimate depression severity. We show that the proposed approaches provide additive improvements in the estimation of depression severity.

Background Prediction of treatment outcomes is a key step in improving the treatment of major depressive disorder (MDD). The Canadian Biomarker Integration Network in Depression (CAN-BIND) aims to predict antidepressant treatment outcomes through analyses of clinical assessment, neuroimaging, and blood biomarkers. Methods In the CAN-BIND-1 dataset of 192 adults with MDD and outcomes of treatment with escitalopram, we applied machine learning models in a nested cross-validation framework. Across 210 analyses, we examined combinations of predictive variables from three modalities, measured at baseline and after 2 weeks of treatment, and five machine learning methods with and without feature selection. To optimize the predictors-to-observations ratio, we followed a tiered approach with 134 and 1152 variables in tier 1 and tier 2 respectively. Results A combination of baseline tier 1 clinical, neuroimaging, and molecular variables predicted response with a mean balanced accuracy of 0.57 (best model mean 0.62) compared to 0.54 (best model mean 0.61) in single modality models. Adding week 2 predictors improved the prediction of response to a mean balanced accuracy of 0.59 (best model mean 0.66). Adding tier 2 features did not improve prediction. Conclusions A combination of clinical, neuroimaging, and molecular data improves the prediction of treatment outcomes over single modality measurement. The addition of measurements from the early stages of treatment adds precision. Present results are limited by lack of external validation. To achieve clinically meaningful prediction, the multimodal measurement should be scaled up to larger samples and the robustness of prediction tested in an external validation dataset.